De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

EMBO Mol Med · 2025 · PMC12423300 · PMID 40707702

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Analysis of TCGA series indicated that PM patients with genetic alterations of NF2 had poorer overall survival, although this did not reach statistical significance (Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.